• Disease areas
  • Science & technology
  • Partnering
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Patients
  • Investors
  • News & media
  • Healthcare professionals
  • Contact us

Latest news

{{'2026-02-04T14:53:59Z' | dateFormatFilter}}

Novo Nordisk files annual report with the SEC

Read more

{{'2026-02-04T07:00:42Z' | dateFormatFilter}}

Novo Nordisk initiates 2026 share repurchase programme

Read more

{{'2026-02-04T06:30:58Z' | dateFormatFilter}}

Novo Nordisk has published its annual report for 2025

Read more

News archive

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Explore our digital Annual Report 2025 Conference calls & other events Visit Capital Markets day Stock information Press releases and company announcements R&D Pipeline

Annual Report

Cover page of the Novo Nordisk Annual Report 2025

Annual Report 2025

Download Annual Report

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

  • Report a side effect
  • Patient help
  • Supplier help
  • Product list
  • Contact us
  • Our Purpose - Code of conduct
  • ESG reporting
  • Novo Nordisk Foundation

Follow us

  • Social media community guidelines
  • LinkedIn
  • YouTube
  • Facebook
  • X (Twitter)
  • Instagram
  • TikTok

Find your local office

Select location
© 2026 Novo Nordisk A/S
Data Privacy
Cookie policy
Cookie settings

change